Status:
COMPLETED
Nutritional Assessment in Idiopathic Pulmonary Fibrosis
Lead Sponsor:
San Gerardo Hospital
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
Brief Summary
In recent years nutritional status assumed increasing importance in the evaluation of chronic respiratory diseases, considering that their clinical course is often characterized by a progressive loss ...
Detailed Description
Preliminary studies on Idiopathic Pulmonary Fibrosis (IPF) seem to suggest that nutritional status has an impact on clinical outcomes, as already demonstrated in COPD. However, few data regarding this...
Eligibility Criteria
Inclusion
- age greater than or equal to 18 years;
- diagnosis of IPF according to the ATS / ERS 2011 guidelines with multidisciplinary discussion
Exclusion
- severe renal failure, defined as a GFR (glomerular filtration rate) lower than 30ml / min;
- NYHA class IV;
- severe liver failure, defined as Child-Pugh score class C;
- active solid or haematological neoplasms;
- having already received (currently or in the past) therapy with pirfenidone or nintedanib;
- inability to walk without help;
- need for oxygen therapy at rest;
- participation in other interventional experimental protocols with use of a medicinal product.
Key Trial Info
Start Date :
December 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03770845
Start Date
December 10 2018
End Date
September 1 2021
Last Update
September 29 2021
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
INRCA Casatenovo
Casatenovo, Lecco, Italy
2
San Gerardo Hospital
Monza, MB, Italy, 20900
3
G. Salvini Hospital
Garbagnate Milanese, Milano, Italy
4
Ospedale di Circolo
Busto Arsizio, Varese, Italy